Carmine F. Palermo

Carmine F. Palermo

Auto-generated profile, based on publicly available information

Carmine F. Palermo

Columbia University Medical Center 1 Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center New York, New York

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
MHMarie Christin Hasselluhn
Marie Christin Hasselluhn
ADAmanda R. Decker-Farrell
Amanda R. Decker-Farrell
LVLukas J Vlahos
Lukas J Vlahos
DTDafydd H. Thomas
Dafydd H. Thomas
ACAlvaro Curiel-Garcia
Alvaro Curiel-Garcia
KOKenneth P. Olive
Kenneth P. Olive
The sparse vascularity of pancreatic ductal adenocarcinoma (PDAC) presents a mystery: What prevents this aggressive malignancy from undergoing neoangiogenesis to counteract hypoxia and better support growth? An incidental finding from prior work on paracrine communication between malignant PDAC cells and fibroblasts revealed that inhibition of the Hedgehog (HH) pathway partially relieved angiosuppression, increasing tumor vascularity through unknown mechanisms. Initial efforts to study this phenotype were hindered by difficulties replicating the complex interactions of multiple cell types in vitro. Here we identify a cascade of paracrine signals between multiple cell types that act sequentially to suppress angiogenesis in PDAC. Malignant epithelial cells promote HH signaling in fibroblasts, leading to inhibition of noncanonical WNT signaling in fibroblasts and epithelial cells, thereby limiting VEGFR2-dependent activation of endothelial hypersprouting. This cascade was elucidated using human and murine PDAC explant models, which effectively retain the complex cellular interactions of native tumor tissues.Significance: We present a key mechanism of tumor angiosuppression, a process that sculpts the physiologic, cellular, and metabolic environment of PDAC. We further present a computational and experimental framework for the dissection of complex signaling cascades that propagate among multiple cell types in the tissue environment.This article is featured in Selected Articles from This Issue, p. 201

31 December 2025 in Cancer Research
Verified
Journal Article
Closed access
HKHiroki Kobayashi
Hiroki Kobayashi
YOYosuke Ochiai
Yosuke Ochiai
Junya AraiJunya Arai
Junya Arai
MHMasahiro Hata
Masahiro Hata
FWFeijing Wu
Feijing Wu
TWTimothy Wang
Timothy Wang
Nerves can regulate tumorigenesis and cancer progression. However, clarification of the role of axon guidance molecules in tumorigenesis, innervation, and metastasis is required to better understand the tumor-promoting functions of nerves. Using murine KrasG12D-mutant pancreatic organoids, we screened axon guidance molecules and identified netrin-1 upregulation. Netrin-1 was also upregulated in vivo during pancreatic tumorigenesis in humans and mice. Mutant KRAS and β-adrenergic signaling upregulated netrin-1 and its receptor NEO1 in epithelial cells in part through the MAPK pathway. Ex vivo culture of celiac ganglia showed that netrin-1 promoted the axonogenesis of sympathetic neurons through nerve NEO1. In the Pdx1-Cre;LSL-KrasG12D/+ model, knockout (KO) of Ntn1, which encodes netrin-1, decreased sympathetic innervation and the development of pancreatic intraepithelial neoplasia. Treatment of pancreatic tumor organoids with recombinant netrin-1 enhanced cell growth, epithelial–mesenchymal transition (EMT), and cancer stemness with the upregulation of ZEB1 and SOX9 through NEO1-mediated activation of focal adhesion kinase (FAK). In Pdx1-Cre;LSL-KrasG12D/+;LSL-Trp53R172H/+ mice, Ntn1 KO reduced innervation, FAK phosphorylation, and the features of EMT and stemness to extend mouse survival. In a liver metastasis model of pancreatic ductal adenocarcinoma (PDAC), treatment with a netrin-1–neutralizing antibody or tumoral KO of Neo1 reduced ZEB1 and SOX9 and decreased tumor progression. In contrast, netrin-1 overexpression promoted innervation and the progression of PDAC liver metastasis. These data suggest that the netrin-1/NEO1 axis is a key regulator of PDAC progression, directly influencing cancer cell stemness and EMT while indirectly promoting tumor growth through nerves. Inhibiting the netrin-1 pathway could represent a potential therapeutic approach for PDAC. Significance: Netrin-1 promotes pancreatic tumorigenesis and metastasis directly and indirectly through nerves, highlighting the importance of tumor cell-nerve cross-talk in cancer and the potential of netrin-1 blockade as a treatment strategy.

5 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAmanda R. Decker-Farrell
Amanda R. Decker-Farrell
SSStephen A. Sastra
Stephen A. Sastra
THTetsuhiro Harimoto
Tetsuhiro Harimoto
MHMarie Christin Hasselluhn
Marie Christin Hasselluhn
CPCarmine F. Palermo
Carmine F. Palermo
KOKenneth P. Olive
Kenneth P. Olive
Pancreatic ductal adenocarcinoma (PDAC) poses significant challenges for effective treatment, with systemic chemotherapy often proving inadequate due to poor drug delivery and the tumor’s immunosuppressive microenvironment. Engineered bacteria present a novel approach to target PDAC, leveraging their ability to colonize tumors and deliver therapeutic payloads. Here, we engineered probiotic Escherichia coli Nissle 1917 (EcN) to produce the pore-forming Theta toxin (Nis-Theta) and evaluated its efficacy in a preclinical model of PDAC. Probiotic administration resulted in selective colonization of tumor tissue, leading to improved overall survival compared to standard chemotherapy. Moreover, this strain exhibited cytotoxic effects on both primary and distant tumor lesions while sparing normal tissues. Importantly, treatment also modulated the tumor microenvironment by increasing anti-tumor immune cell populations and reducing immunosuppressive markers. These findings demonstrate the potential of engineered probiotic bacteria as a safe and effective therapeutic approach for PDAC, offering promise for improved patient outcomes.

8 February 2024
Verified
Other
Open access
PDF file
MHMarie Christin Hasselluhn
Marie Christin Hasselluhn
ADAmanda R. Decker-Farrell
Amanda R. Decker-Farrell
LVLukas J Vlahos
Lukas J Vlahos
DTDafydd H. Thomas
Dafydd H. Thomas
ACAlvaro Curiel-Garcia
Alvaro Curiel-Garcia
KOKenneth P. Olive
Kenneth P. Olive
Abrogation of SHH signaling fuels hypersprouting in human and murine PDAC explants.

8 February 2024
Verified
Other
Open access
MHMarie Christin Hasselluhn
Marie Christin Hasselluhn
ADAmanda R. Decker-Farrell
Amanda R. Decker-Farrell
LVLukas J Vlahos
Lukas J Vlahos
DTDafydd H. Thomas
Dafydd H. Thomas
ACAlvaro Curiel-Garcia
Alvaro Curiel-Garcia
KOKenneth P. Olive
Kenneth P. Olive
Fibroblast network.Regulatory network for PDAC-associated fibroblasts, listing the inferred transcriptional targets (Target) for each regulatory protein (Regulator). Association weight (AW) and association mode (AM) are scores to quantify strength/direction of interaction. Sign indicates directionality of the interaction (1 = transactivating, -1 = transrepressing).

8 February 2024
Verified
Other
Open access
MHMarie Christin Hasselluhn
Marie Christin Hasselluhn
ADAmanda R. Decker-Farrell
Amanda R. Decker-Farrell
LVLukas J Vlahos
Lukas J Vlahos
DTDafydd H. Thomas
Dafydd H. Thomas
ACAlvaro Curiel-Garcia
Alvaro Curiel-Garcia
KOKenneth P. Olive
Kenneth P. Olive
Supplementary Table 10: Antibodies for IHC and IF.Overview of antibodies used for stainings in human PDAC or KPC-derived tissues.Supplementary Table 11: Primer sequences for qRT-PCR.Primers for qRT-PCR-based quantification of ChIP and mRNA samples.Supplementary Table 12: Freezer dryer settings for sponge production.Specific settings for optimal sponge production.Supplementary Table 13: Explant media composition.List of reagents used for human PDAC and murine explants.